The aim of this study was to establish the relative importance of risk factors for mortality after acute upper gastrointestinal haemorrhage, and to formulate a simple numerical scoring system that categorises patients by risk. A prospective, unselected, multicentre, population based study was undertaken using standardised questionnaires in two phases one year apart. 
nosis, major stigmata of recent haemorrhage, and rebleeding are all independent predictors of mortality when assessed using multiple logistic regression. A numerical score using these parameters has been developed that closely follows the predictions generated by logistical regression equations. Haemoglobin, sex, presentation (other than shock), and drug therapy (non-steroidal anti-inflammatory drugs and anticoagulants) are not represented in the final model. When tested for general applicability in a second population, the scoring system was found to reproducibly predict mortality in each risk category. In conclusion, a simple numerical score can be used to stigmata of recent haemorrhage, and rebleeding are all independently significant factors in the prediction of mortality in these models. A simple risk score has been devised using only these significant variables. An integer score was attributed to each category of each Risk score variable according to its relative contribution in the logistic regression model (as determined by its regression coefficient). The score was then adapted so that the outcome in each category most closely fitted the predictions of the logistic regression model. Age and degree of shock were categorised and each attributed a score of 0, 1, or 2. Comorbidity was categorised and attributed a score of 0, 2, or 3. This gives a maximum additive score of 7 before diagnosis.
A score of 0, 1, or 2 for diagnosis and 0 or 2 for stigmata of recent haemorrhage was then added to give a maximum score of 11. Scores of 8 or more are considered as one category as there are very few cases in these very high risk categories. Table III shows the derived scoring system.
The population experiencing further haemorrhage is considered separately from the population without further haemorrhage in the complete model. Table IV shows the observed mortality and rebleeding rate in each category for both models. Figure 1 shows these data for the complete model. Mortality increases in a stepwise fashion as the risk score increases. The rate of rebleeding also increases as the risk score increases. There were no deaths in categories 0 and 1 of the full model and only one death (0°3%) in category 2. Twenty six per cent of the sample were in these lowest three categories. The population that rebled experienced a fivefold increase in mortality in risk group 3, which decreased to a twofold increase for risk group 8. Figure 2 shows the degree of association between the predictions of the full logistical regression model and the observed mortality in each category of the risk score. The box plots represent the distribution of predicted Risk a~e Figure 2 : Boxplot ofcomputer predicted mortality by risk score. mortalities (using the logistic regression equation) for cases within each risk score category. It can be seen that there is a high degree of association between the predictions of the logistic regression model and the greatly simplified numerical score. The risk score has been validated in a second population of 1625 cases collected using an identical methodology as part of the second phase of the National Audit. All the necessary variables were recorded in 1584 cases. In 1190 cases, variables for endoscopic diagnosis and stigmata of recent haemorrhage were also recorded. It can be seen in Table V that the predicted outcomes, based upon the observed outcome by risk category in the first audit, are not significantly different from the observed outcome in the second audit in either the initial or complete models.
Validation

Discussion
There is a great deal more published about the risk factors for rebleeding than for mortality after an acute episode ofhaemorrhage from the upper gastrointestinal tract. Studies of both rebleeding and mortality show that the risk factors for these two outcomes are similar, with the additional conclusion that rebleeding is itself of independent predictive value for mortality.
Univariate analyses have led us to believe that rebleeding increases mortality between five and 16-fold, and perhaps as a result it is Systems such as this are likely to become more important as the discipline of comparative audit expands and the threat of league tables looms. As an adjunct to clinical judgement, it might also be useful in the clinical setting as an index of prognosis both before and after a definitive endoscopic diagnosis.
It might also be used in the development of treatment protocols. The full array of management tools for optimal care of patients with upper gastrointestinal haemorrhage is expensive. Rapid endoscopy by experienced endoscopists on call 24 hours per day, high dependency units, medicosurgical collaboration, and on call endoscopy staff all have considerable financial implications. Being able to select patients that will benefit the most from intensive treatment is one important step in the rationalisation of resources. Early discharge or even outpatient treatment of very low risk groups or the transfer to intensive care facilities of very high risk cases for whom a determined effort to save life is being made, might easily be incorporated into a treatment protocol, however, the use of such a system in selecting patients for surgery could only be promoted after evidence from clinical trials.
It is important to understand that this system, like most predictive methods cannot predict the outcome of any individual patient, except perhaps those in categories 0 and 1 in whom no deaths occurred. The risk of death is simply a measurement of the number of deaths that might be expected in a large population of cases with those risk factors. The testing of the model in a second large population has, however, allowed us to confirm the general applicability of the model based upon current standards of treatment. 
